News

Axalta Coating Systems (AXTA) is expected to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended December 2025. This widely-known

Zimmer Biomet (ZBH) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Wall Street expects a year-over-year decline in earnings on higher revenues when Red Rock Resorts (RRR) reports results for the quarter ended December 2025. While this widely-known consensus

The market expects Xylem (XYL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Wall Street expects a year-over-year increase in earnings on higher revenues when Cloudflare (NET) reports results for the quarter ended December 2025. While this widely-known consensus outlook is

Wall Street expects a year-over-year decline in earnings on lower revenues when Rapid7 (RPD) reports results for the quarter ended December 2025. While this widely-known consensus outlook is

The market expects Hasbro (HAS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

The market expects Fidelity National Information Services (FIS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This

Wall Street expects a year-over-year decline in earnings on higher revenues when Mirion Technologies, Inc. (MIR) reports results for the quarter ended December 2025. While this widely-known

GXO Logistics (GXO) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Duke Energy (DUK) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

The market expects Ecolab (ECL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Wall Street expects a year-over-year decline in earnings on higher revenues when CVS Health (CVS) reports results for the quarter ended December 2025. While this widely-known consensus outlook is

Assurant (AIZ) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives

The market expects American International Group (AIG) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This

Mattel (MAT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a

Wall Street expects a year-over-year decline in earnings on lower revenues when Ford Motor Company (F) reports results for the quarter ended December 2025. While this widely-known consensus outlook

The fourth-quarter 2025 reporting cycle for the Medical sector is about to pick up pace this week, as most firms are slated to share their earnings results over the next two weeks. The sector mainly

Costco Wholesale Corporation’s COST membership-driven business model remains a key competitive advantage, driving reliable revenue growth and strong cash flow. High renewal rates and disciplined

Aldeyra Therapeutics, Inc. (ALDX) closed the last trading session at $5.43, gaining 28.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

From a technical perspective, Graco Inc. (GGG) is looking like an interesting pick, as it just reached a key level of support. GGG's 50-day simple moving average crossed above its 200-day simple

Shares of Janux Therapeutics, Inc. (JANX) have gained 1.8% over the past four weeks to close the last trading session at $13.99, but there could still be a solid upside left in the stock if

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different